These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 19076855)

  • 81. The prognostic significance of bundle branch block in high-risk chronic stable vascular disease patients: a report from the HOPE trial.
    Sumner G; Salehian O; Yi Q; Healey J; Mathew J; Al-Merri K; Al-Nemer K; Mann JF; Dagenais G; Lonn E;
    J Cardiovasc Electrophysiol; 2009 Jul; 20(7):781-7. PubMed ID: 19298567
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Elevated depression symptoms predict long-term cardiovascular mortality in patients with atrial fibrillation and heart failure.
    Frasure-Smith N; Lespérance F; Habra M; Talajic M; Khairy P; Dorian P; Roy D;
    Circulation; 2009 Jul; 120(2):134-40, 3p following 140. PubMed ID: 19564557
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Risk stratification of mortality in patients with heart failure and left ventricular ejection fraction >35%.
    Cygankiewicz I; Zareba W; Vazquez R; Bayes-Genis A; Pascual D; Macaya C; Almendral J; Fiol M; Bardaji A; Gonzalez-Juanatey JR; Nieto V; Valdes M; Cinca J; de Luna AB;
    Am J Cardiol; 2009 Apr; 103(7):1003-10. PubMed ID: 19327431
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Heart failure treatment in the elderly.
    Khangura J; Goodlin SJ
    Expert Rev Cardiovasc Ther; 2011 Sep; 9(9):1171-9. PubMed ID: 21932960
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Advances in heart failure: Minnesota's role in the NHLBI's Heart Failure Network.
    Bart BA
    Minn Med; 2008 Jan; 91(1):40-2. PubMed ID: 18269068
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Physiopathology of heart failure and new approach to the therapy].
    Yazaki Y
    Nihon Naika Gakkai Zasshi; 1995 Sep; 84(9):1449-53. PubMed ID: 8537748
    [No Abstract]   [Full Text] [Related]  

  • 87. Albuminuria in heart failure: what do we really know?
    Dobre D; Nimade S; de Zeeuw D
    Curr Opin Cardiol; 2009 Mar; 24(2):148-54. PubMed ID: 19532101
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Establishing prognosis in heart failure: a multimarker approach.
    Ketchum ES; Levy WC
    Prog Cardiovasc Dis; 2011; 54(2):86-96. PubMed ID: 21875508
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.
    Triposkiadis F; Karayannis G; Giamouzis G; Skoularigis J; Louridas G; Butler J
    J Am Coll Cardiol; 2009 Nov; 54(19):1747-62. PubMed ID: 19874988
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Prehospital management of congestive heart failure.
    Mattu A; Lawner B
    Heart Fail Clin; 2009 Jan; 5(1):19-24, v. PubMed ID: 19026382
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Statin use is associated with improved survival in patients with advanced heart failure receiving resynchronization therapy.
    Sumner AD; Boehmer JP; Saxon LA; Carson P; Feldman AM; Galle E; Bristow MR
    Congest Heart Fail; 2009; 15(4):159-64. PubMed ID: 19627288
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Optimizing therapy for complex or refractory heart failure: a management algorithm.
    Stevenson LW; Massie BM; Francis GS
    Am Heart J; 1998 Jun; 135(6 Pt 2 Su):S293-309. PubMed ID: 9630092
    [No Abstract]   [Full Text] [Related]  

  • 93. Effect of pulmonary hypertension on clinical outcomes in advanced heart failure: analysis of the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) database.
    Khush KK; Tasissa G; Butler J; McGlothlin D; De Marco T;
    Am Heart J; 2009 Jun; 157(6):1026-34. PubMed ID: 19464413
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The MUSIC Risk score: a simple method for predicting mortality in ambulatory patients with chronic heart failure.
    Vazquez R; Bayes-Genis A; Cygankiewicz I; Pascual-Figal D; Grigorian-Shamagian L; Pavon R; Gonzalez-Juanatey JR; Cubero JM; Pastor L; Ordonez-Llanos J; Cinca J; de Luna AB;
    Eur Heart J; 2009 May; 30(9):1088-96. PubMed ID: 19240065
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients.
    Vijan SG
    J Indian Med Assoc; 2009 Mar; 107(3):178-82. PubMed ID: 19810392
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Management of hypertension in chronic heart failure.
    Manickavasagam S; Merla R; Koerner MM; Fujise K; Kunapuli S; Rosanio S; Barbagelata A
    Expert Rev Cardiovasc Ther; 2009 Apr; 7(4):423-33. PubMed ID: 19379066
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Hyperuricemia in acute heart failure. More than a simple spectator?
    Alimonda AL; Núñez J; Núñez E; Husser O; Sanchis J; Bodí V; Miñana G; Robles R; Mainar L; Merlos P; Darmofal H; Llácer A
    Eur J Intern Med; 2009 Jan; 20(1):74-9. PubMed ID: 19237097
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Ultrafiltration does not affect certain predictors of outcome in heart failure.
    Kazory A
    Int J Cardiol; 2010 Aug; 143(1):1-3. PubMed ID: 20207034
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Ultrafiltration for volume control in decompensated heart failure.
    Haas GJ; Pestritto VM; Abraham WT
    Heart Fail Clin; 2008 Oct; 4(4):519-34. PubMed ID: 18760762
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis.
    Pantalone KM; Kattan MW; Yu C; Wells BJ; Arrigain S; Jain A; Atreja A; Zimmerman RS
    Acta Diabetol; 2009 Jun; 46(2):145-54. PubMed ID: 19194648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.